Cited by 46Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMedical Imaging Techniques and Applications

The added value of 18-fluorodeoxyglucose-positron emission tomography in the diagnosis of the behavioral variant of frontotemporal dementia

Open access
Kerklaan, B. J., van Berckel, B. N. M., Herholz, K., Dols, A., van der Flier, W. M., Scheltens, P., Pijnenburg, Y. A. L.·2014·American Journal of Alzheimer's Disease & Other Dementias®

Abstract

Characteristic frontotemporal abnormalities on structural or functional neuroimaging are mandatory for a diagnosis of probable behavioral variant of frontotemporal dementia (bvFTD) according to the new criteria. 18-Fluorodeoxyglucose-positron emission tomography (18F-FDG-PET) imaging is commonly reserved for patients with suspected bvFTD without characteristic structural neuroimaging results. We studied the diagnostic value of 18F-FDG-PET in these patients. Methods: The 18F-FDG-PET was performed in 52 patients with suspected bvFTD but lacking characteristic structural neuroimaging results. The clinical diagnosis of bvFTD in the presence of functional decline (bvFTD/fd+) after a follow-up period of 2 years was used as a golden standard. Results: The sensitivity of 18F-FDG-PET for bvFTD/fd+ was 47% at a specificity of 92%. The differential diagnosis comprised alternative neurodegenerative and psychiatric disorders and a benign phenocopy of bvFTD. Conclusions: The 18F-FDG-PET is able to identify nearly half of the patients with bvFTD who remain undetected by magnetic resonance imaging. In our selected group, high specificity enables exclusion of psychiatric and other neurodegenerative disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1533317514524811

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • FDG-PET in 52 patients with suspected bvFTD but no characteristic atrophy on structural imaging was 47% sensitive and 92% specific.

    “FDG-PET performed in 52 patients with suspected bvFTD but not having characteristic atrophy patterns on structural imaging was 47% sensitive and 92% specific, showing that is able to identify nearly half of the patients with bvFTD undetected by MRI with high specificity, enabling exclusion of psychiatric and other neurodegenerative disorders [132].”
  • PET provides a higher imaging sensitivity by identifying half of the bvFTD cases that remain undetected by MRI techniques.

    “PET provides a higher imaging sensitivity by identifying half of the bvFTD cases that remain undetected by MRI techniques (Kerklaan et al. , 2014).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 29

  1. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurol- ogy. 1998;51(6):1546-1554.
  2. Knopman DS, Boeve BF, Parisi JE, et al. Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol. 2005;57(4): 480-488.
  3. Mendez MF. The accuracy of clinical criteria for the diagnosis of frontotemporal dementia. Int J Psychiatry Med. 2004;34(2): 125-130.
  4. Piguet O, Hornberger M, Shelley BP, Kipps CM, Hodges JR. Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia. Neurology. 2009;72(8): 732-737.
  5. Pijnenburg YA, Mulder JL, van Swieten JC, et al. Diagnostic accuracy of consensus diagnostic criteria for frontotemporal dementia in a memory clinic population. Dement Geriatr Cogn Disord. 2008;25(2):157-164.
  6. Rascovsky K, Hodges JR, Kipps CM, et al. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord. 2007;21(4):S14-S18.
  7. Gregory CA, Hodges JR. Clinical features of frontal lobe demen- tia in comparison to Alzheimer's disease. J Neural Transm Suppl. 1996;47:103-123.
  8. Panegyres PK, Graves A, Frencham KA. The clinical differentia- tion of fronto-temporal dementia from psychiatric disease. Neuropsychiatr Dis Treat. 2007;3(5):637-645.
  9. Mendez MF, Shapira JS, McMurtray A, Licht E, Miller BL. Accuracy of the clinical evaluation for frontotemporal dementia. Arch Neurol. 2007;64(6):830-835.
  10. Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. The diagnostic challenge of psychiatric symptoms in neurodegenera- tive disease: rates of and risk factors for prior psychiatric diagno- sis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011;72(2):126-133.
  11. Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DM, Neary D. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1999;66(2):184-188.
  12. Mendez MF, Selwood A, Mastri AR, Frey WH. Pick's disease versus Alzheimer's disease: a comparison of clinical characteris- tics. Neurology. 1993;43(2):289-292.
  13. Rosen HJ, Hartikainen KM, Jagust W, et al. Utility of clinical cri- teria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology. 2002;58(11):1608-1615.
  14. Josephs KA, Whitwell JL, Jack CR, Parisi JE, Dickson DW. Frontotemporal lobar degeneration without lobar atrophy. Arch Neurol. 2006;63(11):1632-1638.
  15. Koedam EL, Van der Flier WM, Barkhof F, Koene T, Scheltens P, Pijnenburg YA. Clinical characteristics of patients with fronto- temporal dementia with and without lobar atrophy on MRI. Alzheimer Dis Assoc Disord. 2010;24(3):242-247.
  16. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand. 2000;101(1):11-20.
  17. Erkwoh R, Sabri O, Steinmeyer EM, Bu ¨ll U, Sab H. Psychopatho- logical and SPECT findings in never-treated schizophrenia. Acta Psychiatr Scand. 1997;96(1):51-57.
  18. Sachdev P, Brodaty H, Rose N, Haindl W. Regional cerebral blood flow in late-onset schizophrenia: a SPECT study using 99mTc-HMPAO. Schizophren Res. 1997;27(2-3):105-117.
  19. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47(5):1113-1124.
  20. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and manage- ment of dementia with Lewy bodies. third report of the DLB consortium. Neurology. 2005;65(12):1863-1872.
  21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 1984;34(7):939-944.
  22. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular demen- tia: diagnostic criteria for research studies. Report of the NINDS- AIREN international workshop. Neurology. 1993;43(2):250-260.
  23. Folstein MF, Folstein SE, McHugh PR. ''Mini-mental state.'' A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1995;12(3):189-198.
  24. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55(11): 1621-1626.
  25. Brix G, Zaers J, Adam LE, et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. national electrical manufacturers association. J Nucl Med. 1997;38(10): 1614-1623.
  26. Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multi- center FDG PET. Neuroimage. 2002;17(1):302-316.
  27. Khan BK, Yokoyama JS, Takada LT, et al. Atypical, slowly pro- gressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatry. 2012;83(4):358-364.
  28. Kipps CM, Hodges JR, Hornberger M. Nonprogressive behavioural frontotemporal dementia: recent developments and clinical implications of the 'bvFTD phenocopy syndrome'. Curr Opin Neurol. 2010;23(6):628-632.
  29. Diehl-Schmid J, Grimmer T, Drzezga A, et al. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging. 2007;28(1):42-50.

Cited by

Sorted by citations

Authors
Kerklaan, B. J., van Berckel, B. N. M., Herholz, K., Dols, A., van der Flier, W. M., Scheltens, P., & Pijnenburg, Y. A. L.
Affiliations
  • Sint Lucas Andreas Hospital (NL)
  • Department of Nuclear Medicine, VU Medical Center, Amsterdam, The Netherlands
  • University of Manchester (GB)
  • GGZ inGeest (NL)
  • Alzheimer Center VU Medical Center, Amsterdam, The Netherlands
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Corresponding author
Kerklaan, B. J.
Venue
American Journal of Alzheimer's Disease & Other Dementias®
Published
2014-02-26
Volume
29
Issue
7
Pages
607-613
ISSN
  • 0888-4897 (ISSN-L)
  • 1533-3175
  • 1938-2731
OpenAlex
W2168210007
Cited by
46
References
3
Citations by year
2026: 4 · 2025: 5 · 2024: 3 · 2023: 1 · 2021: 5 · 2020: 2 · 2019: 7 · 2018: 6 · 2016: 7 · 2015: 4 · 2014: 2
FWCI
3.31
Type
journal article
Language
en
Open access
Locations
  • American Journal of Alzheimer s Disease & Other Dementias® (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
behavioral variant frontotemporal dementia, 18F-FDG PET, diagnostic accuracy, sensitivity and specificity, differential diagnosis, mental illness, neurodegenerative diseases, phenocopy, functional decline, magnetic resonance imaging
MeSH terms
Cerebrospinal Fluid, Diagnosis, Differential, Electroencephalography, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Retrospective Studies, Sensitivity and Specificity, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography, Frontotemporal Dementia, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review